100
Participants
Start Date
June 1, 2025
Primary Completion Date
July 30, 2026
Study Completion Date
July 30, 2026
Ilioinguinal/iliohypogastric Nerve Block
15cc 0.25% of Bupivacaine + Dexamethasone 8 mg 2cc
Ilioinguinal/iliohypogastric with Placebo Block
17 cc of Placebo
Makassed General Hospital, Beirut
Makassed General Hospital
OTHER